Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot.

Mateo M, Reynard S, Carnec X, Journeaux A, Baillet N, Schaeffer J, Picard C, Legras-Lachuer C, Allan R, Perthame E, Hillion KH, Pietrosemoli N, Dillies MA, Barrot L, Vallve A, Barron S, Fellmann L, Gaillard JC, Armengaud J, Carbonnelle C, Raoul H, Tangy F, Baize S.

Sci Transl Med. 2019 Oct 2;11(512). pii: eaaw3163. doi: 10.1126/scitranslmed.aaw3163.


Non-Pathogenic Mopeia Virus Induces More Robust Activation of Plasmacytoid Dendritic Cells than Lassa Virus.

Schaeffer J, Reynard S, Carnec X, Pietrosemoli N, Dillies MA, Baize S.

Viruses. 2019 Mar 21;11(3). pii: E287. doi: 10.3390/v11030287.


Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells.

Schaeffer J, Carnec X, Reynard S, Mateo M, Picard C, Pietrosemoli N, Dillies MA, Baize S.

PLoS Pathog. 2018 Nov 12;14(11):e1007430. doi: 10.1371/journal.ppat.1007430. eCollection 2018 Nov.


TIM-1 Ubiquitination Mediates Dengue Virus Entry.

Dejarnac O, Hafirassou ML, Chazal M, Versapuech M, Gaillard J, Perera-Lecoin M, Umana-Diaz C, Bonnet-Madin L, Carnec X, Tinevez JY, Delaugerre C, Schwartz O, Roingeard P, Jouvenet N, Berlioz-Torrent C, Meertens L, Amara A.

Cell Rep. 2018 May 8;23(6):1779-1793. doi: 10.1016/j.celrep.2018.04.013.


A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.

Carnec X, Mateo M, Page A, Reynard S, Hortion J, Picard C, Yekwa E, Barrot L, Barron S, Vallve A, Raoul H, Carbonnelle C, Ferron F, Baize S.

J Virol. 2018 May 29;92(12). pii: e02230-17. doi: 10.1128/JVI.02230-17. Print 2018 Jun 15.


The Phosphatidylserine and Phosphatidylethanolamine Receptor CD300a Binds Dengue Virus and Enhances Infection.

Carnec X, Meertens L, Dejarnac O, Perera-Lecoin M, Hafirassou ML, Kitaura J, Ramdasi R, Schwartz O, Amara A.

J Virol. 2015 Oct 14;90(1):92-102. doi: 10.1128/JVI.01849-15. Print 2016 Jan 1.


Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response.

Reynard S, Russier M, Fizet A, Carnec X, Baize S.

J Virol. 2014 Dec;88(23):13923-7. doi: 10.1128/JVI.01923-14. Epub 2014 Sep 24.


The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses.

Russier M, Reynard S, Carnec X, Baize S.

J Virol. 2014 Dec;88(23):13811-20. doi: 10.1128/JVI.01908-14. Epub 2014 Sep 24.


Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication.

Sahin U, Ferhi O, Carnec X, Zamborlini A, Peres L, Jollivet F, Vitaliano-Prunier A, de Thé H, Lallemand-Breitenbach V.

Nat Commun. 2014 Jun 19;5:4187. doi: 10.1038/ncomms5187.


Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever.

Pannetier D, Reynard S, Russier M, Carnec X, Baize S.

PLoS Negl Trop Dis. 2014 Jan 9;8(1):e2637. doi: 10.1371/journal.pntd.0002637. eCollection 2014.


Flavivirus entry receptors: an update.

Perera-Lecoin M, Meertens L, Carnec X, Amara A.

Viruses. 2013 Dec 30;6(1):69-88. doi: 10.3390/v6010069. Review.


Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis.

Carnec X, Ermonval M, Kreher F, Flamand M, Bouloy M.

Virology. 2014 Jan 5;448:1-14. doi: 10.1016/j.virol.2013.09.023. Epub 2013 Oct 16.


The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry.

Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, Lew E, Lemke G, Schwartz O, Amara A.

Cell Host Microbe. 2012 Oct 18;12(4):544-57. doi: 10.1016/j.chom.2012.08.009.


Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages.

Carnec X, Baize S, Reynard S, Diancourt L, Caro V, Tordo N, Bouloy M.

J Virol. 2011 Nov;85(22):12093-7. doi: 10.1128/JVI.00429-11. Epub 2011 Aug 31.


Supplemental Content

Loading ...
Support Center